Plastiblends India Limited (PLASTIBLEN.NS)
Mumbai, IN
Plastiblends India Limited is a key player in India's plastic processing sector, specializing in the production and supply of diverse color and additive masterbatches, as well as thermoplastic compounds. Its extensive portfolio features various masterbatch types, including white, black, colored, additive, filler, and PET, alongside specialized conductive compounds and engineering polymers. These solutions cater to a broad array of markets, such as agriculture, appliances, automotive and transportation, healthcare and pharmaceuticals, packaging, textiles, wire and cable, and the electrical, electronics, and telecommunications industries. Beyond its domestic operations, the company boasts an international presence, exporting its products to around 40 nations. Founded in 1991, Plastiblends India Limited is based in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.59% | +2.47% | +5.11% | +29.46% | +6.70% | +5.77% | -14.71% | -6.70% | -29.37% | -17.09% | +277.79% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Chemicals - Specialty: +4.7%+1.1% Q1'26: +5.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+9.7% Q1'26: +44.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.3% Q1'26: -9.9% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.8% Q1'26: +7.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+6.7% ★ Q1'26: +10.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.42× ★ Q1'26: 0.29× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.77B
est: 2.79B (-0.8%)
|
4.94B
est: 5.01B (-1.3%)
|
5.20B
est: 5.00B (+4.0%)
|
5.45B
est: 5.76B (-5.4%)
|
5.64B
est: 6.23B (-9.5%)
|
6.23B
est: 6.44B (-3.3%)
|
5.98B
est: 6.27B (-4.6%)
|
5.77B
est: 6.90B (-16.3%)
|
7.14B
est: 7.16B (-0.2%)
|
7.69B
est: 7.42B (+3.6%)
|
7.80B
est: 5.00B (+56.2%)
|
5.00B
5.00B – 5.00B
+0.0% YoY
|
5.76B
5.76B – 5.76B
+15.3% YoY
|
6.23B
6.23B – 6.23B
+8.2% YoY
|
6.44B
6.44B – 6.44B
+3.3% YoY
|
6.27B
6.27B – 6.27B
-2.6% YoY
|
6.90B
6.90B – 6.90B
+10.0% YoY
|
| EBITDA |
304.53M
est: 242.58M (+25.5%)
|
504.13M
est: 434.96M (+15.9%)
|
616.51M
est: 434.15M (+42.0%)
|
651.64M
est: 500.71M (+30.1%)
|
572.63M
est: 541.64M (+5.7%)
|
614.86M
est: 559.66M (+9.9%)
|
705.41M
est: 545.06M (+29.4%)
|
720.45M
est: 599.57M (+20.2%)
|
681.68M
est: 765.42M (-10.9%)
|
541.17M
est: 647.94M (-16.5%)
|
519.75M
est: 376.61M (+38.0%)
|
376.61M
376.61M – 376.61M
+0.0% YoY
|
434.35M
434.35M – 434.35M
+15.3% YoY
|
469.85M
469.85M – 469.85M
+8.2% YoY
|
485.48M
485.48M – 485.48M
+3.3% YoY
|
472.83M
472.83M – 472.83M
-2.6% YoY
|
520.11M
520.11M – 520.11M
+10.0% YoY
|
| EBIT |
266.45M
est: 181.13M (+47.1%)
|
441.74M
est: 324.78M (+36.0%)
|
554.16M
est: 324.17M (+70.9%)
|
544.46M
est: 373.87M (+45.6%)
|
456.11M
est: 404.43M (+12.8%)
|
497.44M
est: 417.88M (+19.0%)
|
534.91M
est: 406.99M (+31.4%)
|
562.09M
est: 447.68M (+25.6%)
|
520.76M
est: 576.72M (-9.7%)
|
377.20M
est: 483.80M (-22.0%)
|
367.52M
est: 274.92M (+33.7%)
|
274.92M
274.92M – 274.92M
+0.0% YoY
|
317.07M
317.07M – 317.07M
+15.3% YoY
|
342.98M
342.98M – 342.98M
+8.2% YoY
|
354.39M
354.39M – 354.39M
+3.3% YoY
|
345.15M
345.15M – 345.15M
-2.6% YoY
|
379.67M
379.67M – 379.67M
+10.0% YoY
|
| Net Income |
185.44M
est: 168.30M (+10.2%)
|
300.51M
est: 329.78M (-8.9%)
|
376.71M
est: 377.04M (-0.1%)
|
327.06M
est: 335.08M (-2.4%)
|
273.15M
est: 396.79M (-31.2%)
|
311.67M
est: 498.91M (-37.5%)
|
371.75M
est: 423.30M (-12.2%)
|
373.47M
est: 487.74M (-23.4%)
|
366.99M
est: 424.04M (-13.5%)
|
268.51M
est: 638.99M (-58.0%)
|
334.42M
est: 377.01M (-11.3%)
|
377.01M
377.01M – 377.01M
+0.0% YoY
|
335.05M
335.05M – 335.05M
-11.1% YoY
|
396.76M
396.76M – 396.76M
+18.4% YoY
|
498.87M
498.87M – 498.87M
+25.7% YoY
|
423.26M
423.26M – 423.26M
-15.2% YoY
|
487.70M
487.70M – 487.70M
+15.2% YoY
|
| SGA |
438.13M
est: 155.93M (+181.0%)
|
255.37M
est: 279.60M (-8.7%)
|
422.61M
est: 279.07M (+51.4%)
|
137.79M
est: 321.86M (-57.2%)
|
164.57M
est: 348.17M (-52.7%)
|
166.83M
est: 359.75M (-53.6%)
|
381.72M
est: 350.37M (+8.9%)
|
421.58M
est: 385.41M (+9.4%)
|
385.27M
est: 976.23M (-60.5%)
|
374.01M
est: 416.50M (-10.2%)
|
422.82M
est: 337.88M (+25.1%)
|
337.88M
337.88M – 337.88M
+0.0% YoY
|
389.68M
389.68M – 389.68M
+15.3% YoY
|
421.53M
421.53M – 421.53M
+8.2% YoY
|
435.55M
435.55M – 435.55M
+3.3% YoY
|
424.20M
424.20M – 424.20M
-2.6% YoY
|
466.62M
466.62M – 466.62M
+10.0% YoY
|
| EPS |
7.14
est: 6.48 (+10.2%)
|
11.57
est: 10.78 (+7.4%)
|
14.50
est: 14.51 (-0.1%)
|
12.58
est: 12.90 (-2.4%)
|
10.51
est: 15.27 (-31.2%)
|
11.99
est: 19.20 (-37.6%)
|
14.30
est: 16.29 (-12.2%)
|
14.37
est: 18.77 (-23.4%)
|
14.12
est: 21.43 (-34.1%)
|
10.33
est: 24.47 (-57.8%)
|
12.87
est: 14.51 (-11.3%)
|
14.51
14.51 – 14.51
+0.0% YoY
|
12.90
12.90 – 12.90
-11.1% YoY
|
15.27
15.27 – 15.27
+18.4% YoY
|
19.20
19.20 – 19.20
+25.7% YoY
|
16.29
16.29 – 16.29
-15.2% YoY
|
18.77
18.77 – 18.77
+15.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-06-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-06-10 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-06-09 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-06-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-06-05 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-06-04 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-06-03 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-06-02 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-06-01 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-26 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-25 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-22 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Satyanarayan Gopilal N. Kabra | Chairman & MD | 15M | male |
| Varun Satyanarayan Kabra | Vice Chairman & MD | 11M | male |
| Anand R. Mundra | Chief Financial Officer | — | male |
| Himanshu Suresh Mhatre | Compliance Officer & Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PLASTIBLEN.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
